-
1دورية أكاديمية
المؤلفون: Zhang, Hua, Nabel, Christopher S., Li, Dezhi, O’Connor, Ruth Í., Crosby, Caroline R., Chang, Sarah M., Hao, Yuan, Stanley, Robyn, Sahu, Soumyadip, Levin, Daniel S., Chen, Ting, Tang, Sittinon, Huang, Hsin-Yi, Meynardie, Mary, Stephens, Janaye, Sherman, Fiona, Chafitz, Alison, Costelloe, Naoise, Rodrigues, Daniel A., Fogarty, Hilda, Kiernan, Miranda G., Cronin, Fiona, Papadopoulos, Eleni, Ploszaj, Magdalena, Weerasekara, Vajira, Deng, Jiehui, Kiely, Patrick, Bardeesy, Nabeel, Vander Heiden, Matthew G., Chonghaile, Triona Ni, Dowling, Catríona M., Wong, Kwok-Kin
المصدر: Journal of Thoracic Oncology ; volume 18, issue 7, page 882-895 ; ISSN 1556-0864
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology
الإتاحة: https://doi.org/10.1016/j.jtho.2023.03.014Test
https://api.elsevier.com/content/article/PII:S1556086423001971?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1556086423001971?httpAccept=text/plainTest -
2دورية أكاديمية
المؤلفون: Pan, Yuanwang, Hao, Yuan, Han, Han, Chen, Ting, Ding, Hailin, Labbe, Kristen E, Shum, Elaine, Guidry, Kayla, Hu, Hai, Sherman, Fiona, Geng, Ke, Stephens, Janaye, Chafitz, Alison, Tang, Sittinon, Huang, Hsin-Yi, Peng, Chengwei, Almonte, Christina, Lopes, Jared E, Losey, Heather C, Winquist, Raymond J, Velcheti, Vamsidhar, Zhang, Hua, Wong, Kwok-Kin
المساهمون: These studies were funded by Alkermes, Waltham, Massachusetts.
المصدر: Journal for ImmunoTherapy of Cancer ; volume 10, issue 9, page e004913 ; ISSN 2051-1426
-
3دورية أكاديمية
المؤلفون: Atsushi Okato1, Takanobu Utsumi1, Ranieri, Michela2, Xingnan Zheng1, Mi Zhou1, Pereira, Luiza D.2, Ting Chen2, Yuki Kita1, Di Wu1, Hyun, Hyesun1, Hyojin Lee3, Gdowski, Andrew S.1, Raupp, John D.1, Clark-Garvey, Sean1, Manocha, Ujjawal1, Chafitz, Alison2, Sherman, Fiona2, Stephens, Janaye2, Rose, Tracy L.1,4, Milowsky, Matthew I.1,4
المصدر: Journal of Clinical Investigation. 1/16/2024, Vol. 134 Issue 2, p1-16. 16p.
مصطلحات موضوعية: *BLADDER cancer, *FIBROBLAST growth factor receptors, *REGULATORY T cells, *IMMUNE checkpoint inhibitors, *PROGRAMMED cell death 1 receptors, *IMMUNOSUPPRESSION